dactylon, and willing to participate were included in the study. If patient was taking any acute medicine, he/she was included in the study after a washout period of 1 week. Exclusion criteria were patients unwilling to participate, patients having a clinical presentation not corresponding with the study medicine, patients on regular medication for any systemic disease, and patients under chronic medicinal treatment. After providing patient information sheet in local vernaculars, informed written consent was obtained from the eligible participants or the guardians in case of minors before participating in the study.
The study medicines were procured from a good manufacturing practice-compliant homoeopathic pharmacy in various potencies, namely, 6C, 30C, 200C, and 1M, and were distributed to above-mentioned institutes/units. First, the presenting signs and symptoms of the patients were recorded in case recording proforma. After that, the symptoms were repertorized using a repertory prepared for clinical verification by the CCRH and then a specially developed Materia Medica [74] was consulted for final selection of the remedy. Later, all these works were incorporated in one book published by CCRH. [64] If the presenting symptoms of the patient corresponded with Cynodon dactylon, then the medicine was prescribed in 6C potency, thrice a day till the improvement or aggravation occurred or for maximum 5-7 days allowing the medicine to act. The medicine was served by corresponding institute/ unit pharmacy. In follow-up visits, the changes in signs and symptoms were noted. If there was any sign of improvement, then placebo was prescribed. If there was status quo, next higher potencies such as 30C were prescribed twice a day for 3-5 days in acute diseases or for 5-7 days for chronic diseases, 200C once a week were prescribed and were observed for 2 weeks; and 1M potencies were advised once a fortnight, followed by 2 weeks observation. Dosage was decided as per the need of the case and in accordance with homoeopathic principles. Any potency could be tried for twice only. If adequate responses were not elicited, the cases were restudied and next higher potency was prescribed. If no change was observed even after the change of potencies also, then the case was closed and considered as a clinical failure or status quo. If the patient presented with new symptoms of mild intensity, placebo was prescribed. Appearance of severe symptoms (new or aggravation of existing symptoms) with sufficient strength to cause considerable discomfort to the patient called for a change of medicine or therapy., Such case was considered as a deteriorated one. "Clinical success" was defined a priori as cases showing clinical improvement, objective or subjective, of present complaint(s) as judged by the investigating physician(s) and/or as reported by the patient(s). "Clinical failures" were such cases showing "status quo" and/or worsening or deterioration of the condition, or cases requiring change of medicines. All the data were collected and compiled in specially designed Excel spreadsheet for analysis. Data were presented using descriptive statistics -mean, standard deviations (SDs), absolute values, percentages, and 95% confidence intervals (CIs). As per protocol, a minimum of two prescriptions for each symptom have been considered for enlisting. Prevalence of the symptoms in the responding and nonresponding population was compared using Chi-square or Fisher's exact test, keeping P < 0.05 two-tailed as statistically significant.
results
A total of 462 patients were enrolled in the study having similar symptomatology with Cynodon dactylon and meeting the pre-specified criteria after screening 25,368 patients from outpatients, for verifying assigned 34 drugs under the clinical verification program of the Council, from October 2005 to March 2010. Of these, 122 dropped out and 340 results were analyzed in the end [ Figure 1 ]. Among the enrolled patients, 204 (60%) were male, rest 136 (40%) were female. The mean age of the patients was 29.7 years (SD = 18.3). Patients spanned all age groups, but majority were from age groups of 19-30 years (n = 103, 30.4%). 261 patients (94.9%) were Hindu, 112 (54.6%) were married, and majority (n = 75, 33.9%) were students by occupation. Mean body mass index (BMI) was 33.1 (SD = 8.9), and most of the patients (n = 85, 42.1%) belonged to obese II BMI range of 35-39.9 . Mean height and weight were 150.1 cm (SD = 24.3) and 50.8 kg (SD = 17.8), respectively. Mean systolic and diastolic blood pressures were 117.2 (SD = 12.0) and 75.3 (SD = 7.3) mm Hg, respectively [ Table 1 ]. There were clinical successes in 274 cases (80.6%) and failures in 66 (19.4%), judged subjectively by the physicians. The clinically verified symptoms were enlisted along with the outcomes on the basis of existing proving records and the symptoms available in other literature, and also the new observations (clinical symptoms), those are not mentioned elsewhere but found to be relieved after administration of the medicine [ Table 2 ]. Among the 340 patients, a total of 32 different types of clinical conditions or diagnoses were obtained. Respiratory tract infection (RTI) was the most frequently recorded clinical diagnosis in the responding population (n = 81; 29.6%), followed by haemorrhoids (n = 51; 18.6%), diarrhoea and dysentery (n = 44; 16.1%), rheumatic ¥ 37.0 (0.7) 36.9, 37.1 ¥ Continuous data presented as mean (SD). SD: Standard deviation; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: Body mass index conditions and myalgia (n = 23; 8.4%), menorrhagia (n = 17; 6.2%), and urolithiasis (n = 11; 4.0%) [ Table 3 ].
After going through the records, namely, proving symptoms of Cynodon dactylon conducted by the Council and already verified symptoms of the drug emerged from earlier verification of the drug in the Council under the same program, the following were the most frequently observed symptoms:
• "Dry cough in morning, at night, with irritation and sore Contd... Contd... Table 2 ].
Among the existing symptoms available from other literature, the most frequently observed symptoms were as follows:
• "Sleep, disturbed, restless" (n = 29, prevalence 7.7% in the responding group, 95% CI: 4.9, 11.6); • "Desires company" (n = 27, prevalence 8.0% in the responding group, 95% CI: 5.2, 12.1) • "Angry easily, on contradiction, without reason, short-tempered" (n = 26, prevalence 8.4% in the responding group, 95% CI: 5.5, 12.5) [ Table 2 ].
Among new clinical symptoms, the most frequently observed symptoms were as follows:
• "Tongue, clean" (n = 245, prevalence 70.1% in the responding group, 95% CI: 64.2, 75.4) • "Appetite diminished" (n = 124, prevalence 35.4% in the responding group, 95% CI: 29.8, 41.4) • "Thermal relation, ambithermal" (n = 100, prevalence 30.7% in the responding group, 95% CI: 25.3, 36.5) [ Table 2 ].
However, there were no statistically significant differences in the prevalence of any of the enlisted symptoms between the responding and nonresponding population [ Table 2 ]. Among the newly observed clinical symptoms, ten were polar -thirst increased versus decreased; tongue clean versus coated; tongue moist versus dry; stool dry, hard versus watery, loose; and sweat scanty versus profuse. RTI and hemorrhoids emerged as the most frequently recorded clinical diagnosis in the responding population [ Table 3 ]. All these findings warrant further research and validation, either by controlled trials and/or by prognostic research.
disCussion
In this observational clinical verification study, a total of 53 symptoms of Cynodon dactylon were verified, of which 43 symptoms were from the proving and clinical verification records, documented after the research carried out previously by the Council and the rest ten were clinical reconfirmation of symptoms from other literature. Besides these, 57 new clinical symptoms were also identified.
Most frequently encountered and improved clinical conditions were RTIs, haemorrhoids, diarrhoea, and dysentery, thus substantiating the traditional uses of Cynodon dactylon. Still, the frequency of prescriptions on the basis of those remained compromised, hindering definite prediction or inference about strength or importance of the symptoms in prescribing the medicine. Currently, likelihood ratio (LR) seems to be the mainstay of future homoeopathic research for confirming the accuracy of the symptoms enlisted under any drug. Retrospective assessment of prevalence and LR of symptoms in good responders could be a mean for better selection of symptoms for prospective research; however, feasibility of conducting such retrospective investigations deserves further discussion. Although the presence and/or absence of Cynodon dactylon symptoms in the "medicine worked" population can be identified in a retrospective way, still finding out the same in the remaining population treated during the study period from the available CCRH database is not feasible; hence, formation of the 2 × 2 contingency table of prognostic research and calculation of LR do not appear to be probable at this point of time. These symptoms of Cynodon dactylon with low prevalence need greater amount of cases to be able to establish a statistically significant LR. All these results should be considered as provisory and need confirmation through prospective research of real prevalence to "tune" homoeopathic medicines' knowledge and more importantly, to increase posterior chance of correct selection of medicine and improve prescription accuracy and clinical outcomes. In addition, we compared responding and nonresponding patients to get some idea of symptoms that can be further investigated; however, no significant difference was obtained in any occasion. The spheres of action of Cynodon dactylon identified were head, nose, respiratory tract, gastrointestinal system, rectum, genitourinary system, musculoskeletal system, and skin. A few mental symptoms were elicited -getting angry easily, anger on contradiction and without reason; short-tempered; desires company; averse to noise, crowd, music; desire to be alone; irritable; averse to mental or physical work, desire to lie down, profound weakness, lethargy; peevish and quarrelsome. Moreover, our initial observation also elicited few polar symptoms -both desire for and aversion to bitter, fish, and sweet; thirst increased and decreased; tongue clean and coated; tongue moist and dry; sweat scanty and profuse; thermally chilly and hot. Apart from the above observations, during the study, a group of valuable symptoms also emerged reflecting the general characters of the medicine and thereby widening the probable scope of its therapeutic applicability. These newly emerged general symptoms may offer promising help during prescription of Cynodon dactylon. These were desire for salty things and sweets, increased appetite, excessive or decreased thirst, and decreased sweat. The mental features obtained were sad, depressed, melancholic mood; forgetful and weak memory; irritability; and aversion to noise, light, and crowd. These may be considered as useful clinical concomitants or associated symptoms, carrying much importance to prescribe the medicine. The overall results were contributed by different study sites, indicating enhanced generalizability of the study findings. However, being an observational trial, this study cannot address the threats to various internal validity issues, for example, absence of randomization and blinding, the placebo effect, the therapeutic relationship with the clinician (empathy, compassion, social desirability, etc.,), the regression effect toward the mean (RTM), and the use of undisclosed concomitant treatments, if any. Another problem incurred by this clinical verification research is the subjective assessment of clinical success or failure by the investigators, subject to bias. Instead, use of validated generic tools (e.g., Glasgow Homoeopathic Hospital Outcome Scale, numeric rating or visual analog scales measuring intensity of the symptoms under question, quality of life indices, etc.,) would have enhanced the acceptability and interpretation of the findings. The causal association can be tested prospectively and systematically in all cases using modified Naranjo criteria [75] in future studies.
ConClusions
This study was conducted to clinically verify the "symptomatology" of Cynodon dactylon by ascertaining the symptoms improved during verification. A total of 53 symptoms of Cynodon dactylon were verified. Further studies are required to confirm the rest of the symptoms. The findings warrant further evaluation using modified study designs and enhanced methodological rigor. On many occasions, a limited number of prescriptions was generated for specific symptoms making interpretation difficult. Calculation of LR will enable more accurate and quantitative description of strength of the probable or claimed characteristic symptoms of the drug, based on empirical evidence instead of assumption. Hence, further confirmation of the symptoms in larger sample size, analysis of polarity, and prospective estimation of LR of the symptoms using Bayesian statistical methods in routine practice are crucial for inclusion of the symptoms in Homoeopathic Materia Medica and Repertory. Estudio clínico, observacional, multicéntrico de verificación homeopática de Cynodon dactylon para mostrar la prevalencia de síntomas en una cohorte de 340 pacientes RESUMEN Contexto: La verificación clínica es un programa de investigación en curso del Council, en el que se han comprobado muchos medicamentos homeopáticos raros. Objetivos: Este estudio se efectuó para verificar clínicamente la "sintomatología" de Cynodon dactylon y establecer la prevalencia de los síntomas grupos "mejorados" y "no mejorados". Materiales y métodos: Se trataba de un estudio clínico, observacional, multicéntrico abierto. Se incluyó un total de 462 pacientes después de comprobar la coincidencia de los síntomas disponibles, el compendio del medicamento y los criterios de elegibilidad de siete unidades/institutos del Council. El medicamento se prescribió en las potencias de 6C, 30C, 200C y 1M, en función de las necesidades de cada paciente, cumpliendo con los principios homeopáticos y el protocolo desarrollado por el Council. Los datos recogidos se presentaron con estadísticas descriptivas. La prevalencia de los síntomas en la población de respondedores y no respondedores se comparó con la prueba de chi cuadrado o la prueba exacta de Fisher, según correspondiera. Resultados: Se analizó un total de 340 casos completos; la proporción de hombres / mujeres era de 204/136 y la edad media se situó en 29,7 años. Conforme a la valoración subjetiva de los médicos, se dieron 274 (80,6%) casos de "éxito clínico" y 66 (19,4%) "fracasos". Como regla general, se consideró un mínimo de dos prescripciones para el listado de cada síntoma. El número de síntomas verificados fue el siguiente: síntomas de patogenesias (n = 43), síntomas de otras bibliografías (n = 10) y observaciones clínicas nuevas (n = 57). Conclusiones: Se verificó un total de 53 síntomas registrados y se identificaron 57 síntomas clínicos nuevos. Es esencial replicar estos estudios y estimar la relación de probabilidad en la práctica clínica general para la confirmación de los síntomas y su incorporación en la bibliografía homeopática. 340 jks fx;ks a ij ij[ks + x, lk;uks Mks u MDVk;yu ds uS nkfud y{k.kks a dk cgq ds a faed] fo"ys 'k.kkRed] gks E;ks iS Fkh uS nkfud lR;kiu dk v/;;uA lkj çla x% uS nkfud lR;kiu ifj"kn~ ds lrr pyus okys ,s ls vuq la /kku dk;Z Øe gS a tgka dbZ nq yZ Hk gks E;ks iS fFkd vkS 'kf/k;ks a dk lR;kiu fd;k tkrk gS a A mís ';% ;g v/;;u nw c ?kkl ¼lk;uks Mks u MDVk;yu½ ds ^uS nkfud y{k.kks a * dks lR;kfir djus vkS j bles a ^lq /kkj* vkS j^ lq /kkj ugha * Js .kh ds y{k. kks a dh la Hkkouk dk irk yxkus ds fy, fd;k x;kA lkexz h vkS j i)fr% ;g v/;;u cgq ds a faed] eq ä] fo"ys 'k.kkRed v/;;u FkkA miyC/k y{k.k ls feyku vkS 'kf/k ds la xz g] vkS j ifj"kn~ dh lkr bdkb;ks a @la LFkkuks a es a ik=rk ekuna M ds lkFk feyku djus ds mijka r dq y 462 jks fx;ks a dk ia thdj.k fd;k x;kA iz R;s d jks xh dh vko';drk ds vuq lkj gks E;ks iS fFkd fl)ka rks a vkS j ifj"kn~ }kjk fodflr çks Vks d‚y ds vuq lkj 6lh] 30lh] 200lh] vkS j 1 ,e iks Vs a lh nok nh x;hA ,d= fd, x, vka dM+ s fooj.kkRed lka f[;dh ds :i es a çLrq r fd;s a x;s a A vuq dw y vkS j iz frdw y tula [;k es a bu y{k.kks a dh O;kidrk dh rq yuk leq fpr #i ls ph&oxZ ijh{k.k ;k fQ'kj lVhd ijh{k.k dk mi;ks x djrs gq , dh x;hA ifj.kke% dq y 340 ekeyks a dk fo'ys "k.k fd;k x;k( iq #"k@efgyk vuq ikr 204%136 o 204@136( vkS lru mez 29-7 lkyA 274 ¼80-6 iz fr"kr½ ds ekeyks a es a ^uS nkfud lQyrk* feyh vkS j 66 ¼19-4 iz fr"kr½ es â vlQyrk* fpfdRldks a }kjk vkRexr :i ls vka dyu fd, x,A iz R;s d y{k.k ds fu/kkZ j.k ds fy, U;w ure nks uq L[kks a ij fopkj fd;k x;kA lR;kfir y{k.kks a dh la [;k bl çdkj gS % iz ekf.kr y{k.k ¼,u ¾ 43½] vU; "kkL= lew gks a ls y{k.k ¼,u ¾ 10½] vkS j u, uS nkfud fo"ys 'k.k ¼,u ¾ 57½A fu"d"kZ % fjdkMZ fd, x, dq y 53 y{k.kks a dk lR;kiu fd;k x;k vkS j 57 u, uS nkfud y{k.kks a dk irk yxk;k x;kA blds vykok gks E;ks iS Fkh lkfgR; es a y{k.kks a dh iq f"V dks 'kkfey djus ds fy, lkekU; vH;kl O;oLFkk es a çfr-fr vkS j la HkkO; vuq ikr dk vuq eku egRo j[krk gS A
